Biomedical Foundation Supports Technology Aimed At Destroying Cancer Cells

A new technology, using electric pulses to destroy cancer tissue and named by NASA Tech Briefs as one of seven key technological breakthroughs of 2007, is receiving additional support aimed at moving the procedure to the marketplace. One of its lead developers, Rafael V. Davalos, a faculty member of the Virginia Tech-Wake Forest University School of Biomedical Engineering and Sciences (SBES) http://www.sbes.vt. Read more ...

FDA issued warning on Amylin's diabetes drug Byetta as the agency found that Byetta has a potential risk for pancreatitis. FDA says 2 patients have died.

Zacks's analyist Mark Vickery realizing the implications for Amylin's stock owners immediate recommended to Sell the stock and avoid the name Amylin. You can already realize how serious is the FDA warning is on Byetta diabetes drug.

Here is what Vickery writes at Zacks.com:

read more

Read more ...